CTC BIO, INC. Logo

CTC BIO, INC.

Develops and manufactures human and animal health products using microbial fermentation.

060590 | KO

Overview

Corporate Details

ISIN(s):
KR7060590007
LEI:
Country:
South Korea
Address:
경기도 화성시 동탄첨단산업1로 27 금강펜테리움IX타워 A동 901호, 화성시

Description

CTC BIO, INC. is a company specializing in the development, manufacturing, and distribution of products for human and animal health. The company leverages core technologies in microbial fermentation and coating to create its product portfolio. Key business areas include human pharmaceuticals, functional foods, and a comprehensive range of animal health solutions. The animal health division offers veterinary medicines, such as antibiotics and coccidiostats, feed additives, and innovative bacteriophage-based products for disease control. In the human health sector, the company provides various pharmaceuticals and is recognized for its advanced manufacturing of probiotics.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-10-31 00:00
주주총회소집결의 (임시주주총회)
Korean 9.2 KB
2024-10-31 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.2 KB
2024-10-25 00:00
주식등의대량보유상황보고서(일반)
Korean 83.2 KB
2024-10-22 00:00
소송등의판결ㆍ결정
Korean 5.5 KB
2024-10-10 00:00
주식등의대량보유상황보고서(일반)
Korean 83.2 KB
2024-09-10 00:00
[기재정정]주식등의대량보유상황보고서(일반)
Korean 113.8 KB
2024-09-10 00:00
주식등의대량보유상황보고서(일반)
Korean 82.9 KB
2024-08-14 00:00
반기보고서 (2024.06)
Korean 1.4 MB
2024-08-12 00:00
주식등의대량보유상황보고서(일반)
Korean 80.0 KB
2024-07-25 00:00
[기재정정]주식등의대량보유상황보고서(일반)
Korean 118.5 KB
2024-07-17 00:00
주식등의대량보유상황보고서(일반)
Korean 79.9 KB
2024-06-19 00:00
주식등의대량보유상황보고서(일반)
Korean 81.7 KB
2024-06-07 00:00
소송등의제기ㆍ신청(경영권분쟁소송) (주주총회 결의 부존재 확인 등)
Korean 10.5 KB
2024-05-31 00:00
소송등의제기ㆍ신청(경영권분쟁소송) (직무집행정지가처분)
Korean 10.6 KB
2024-05-23 00:00
주식등의대량보유상황보고서(일반)
Korean 80.0 KB

Automate Your Workflow. Get a real-time feed of all CTC BIO, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CTC BIO, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for CTC BIO, INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.